MIT Spinout Strand Therapeutics Raises $153 Million To Make Cancerous Tumors Light Up

For years, Jake Becraft has been working at the bleeding edge of cancer research. Now, with solid early clinical results and a boatload of cash he’s hoping to bring his first innovative therapeutic to market by 2030.